Oral fluoroquinolone use and risk of peripheral neuropathy
- 30 September 2014
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 83 (14) , 1261-1263
Abstract
Objective: To quantify the risk of peripheral neuropathy (PN) with oral fluoroquinolone (FQ) use. Methods: We conducted a case-control study within a cohort of men aged 45 to 80 years in the United States followed from 2001 to 2011. Cases were defined as those with the first physician visit diagnosis of PN, polyneuropathy, or drug-induced polyneuropathy. Four controls were matched to each case by age, follow-up, and calendar time using density-based sampling. As a sensitivity analysis, we also quantified the risk of PN with finasteride use, a drug that is not expected to increase the risk of PN. Rate ratios (RRs) for current users of FQs were computed using conditional logistic regression, which was adjusted for chronic renal failure, chronic liver disease, hypothyroidism, postherpetic neuralgia, and the use of nitrofurantoin and metronidazole. Results: We identified 6,226 cases and 24,904 controls. Current users of FQs were at a higher risk of developing PN (RR = 1.83, 95% confidence interval [CI] 1.49–2.27). Current new users had the highest risk (RR = 2.07, 95% CI 1.56–2.74). No risk was observed for current users of finasteride (RR = 1.21, 95% CI 0.97–1.51). Conclusions: Current users, especially new users of FQs, are at a higher risk of developing PN. Despite the increase in the use of FQs, clinicians should weigh the benefits against the risk of adverse events when prescribing these drugs to their patients.Keywords
This publication has 8 references indexed in Scilit:
- Peripheral neuropathy and Guillain-Barré syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysisAnnals of Epidemiology, 2014
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodologyBMJ, 2013
- Fluoroquinolone prescribing in the United States: 1995 to 2002The American Journal of Medicine, 2005
- The nested case-control study in cardiologyAmerican Heart Journal, 2003
- Peripheral Neuropathy Associated with FluoroquinolonesAnnals of Pharmacotherapy, 2001
- Fluoroquinolone Toxicity Profiles: A Review Focusing on Newer AgentsClinical Infectious Diseases, 1999
- Toxicity of QuinolonesDrugs, 1999
- Neurotoxicity of Antibacterial TherapySouthern Medical Journal, 1994